Finance

Lists
Why is ICY down 2.54%?
Dive Deeper
ICY:FRA
Incyte Corp
€ 103.60
-2.54%
(-2.70) 1D
10-р сарын 2, 22:00:00 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ICY...
Open
€ 103.60
High
€ 103.60
Low
€ 103.60
Mkt. cap
23.37 тэрбум
Avg. vol.
25.00
Volume
0.00
52-wk high
€ 115.40
52-wk low
€ 71.56
No. of employees
3 мян
Open
€ 103.60
High
€ 103.60
Low
€ 103.60
Mkt. cap
23.37 тэрбум
Avg. vol.
25.00
Volume
0.00
52-wk high
€ 115.40
52-wk low
€ 71.56
No. of employees
3 мян
News stories
From web sources and news partners
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84 мян
Founded2002
HeadquartersWilmington, Делавар, Америкийн Нэгдсэн Улс
Sector-
Websiteincyte.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
1.37 тэрбум
1.51 тэрбум
1.27 тэрбум
1.67 тэрбум
Cost of goods sold
605.58 сая
732.55 сая
620.43 сая
621.91 сая
Cost of revenue
605.58 сая
732.55 сая
620.43 сая
621.91 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
328.29 сая
388.96 сая
327.06 сая
350.72 сая
Operating expense
328.29 сая
388.96 сая
327.06 сая
350.72 сая
Total operating expenses
933.87 сая
1.12 тэрбум
947.49 сая
972.63 сая
Operating income
432.11 сая
385.32 сая
325.19 сая
701.41 сая
Other non operating income
3.25 сая
4.22 сая
1.75 сая
5.26 сая
EBT including unusual items
482.31 сая
389.94 сая
343.60 сая
751.51 сая
EBT excluding unusual items
461.55 сая
419.71 сая
360.06 сая
744.21 сая
Income tax expense
58.14 сая
90.66 сая
40.27 сая
165.91 сая
Effective tax rate
12.05%
23.25%
11.72%
22.08%
Other operating expenses
-
-
-
-
Net income
424.17 сая
299.28 сая
303.33 сая
585.60 сая
Net profit margin
31.05%
19.86%
23.83%
34.98%
Earnings per share
2.26
1.80
1.81
3.09
Interest and investment income
26.78 сая
30.75 сая
33.69 сая
38.12 сая
Interest expense
-592.00 мян
-582.00 мян
-569.00 мян
-582.00 мян
Net interest expenses
26.19 сая
30.17 сая
33.12 сая
37.54 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
456.13 сая
409.30 сая
348.99 сая
727.89 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс